The Targeted Delivery Interest Group (TDIG) is a NIH multi-institutional team that champions targeted delivery of therapeutics to different organs for selective and effective treatments with reduced harmful effects. The group aims to identify gaps and opportunities to advance basic, translational, and clinical research for multiple delivery platforms applicable for the treatment of multiple diseases including autoimmunity, transplantation, cancers, neurodegeneration, cardiovascular diseases, and infectious diseases.
TDIG Monthly Webinar Series is open to all.
Request for Information (RFI) issued by the Office of Strategic Coordination
This Notice is a time-sensitive RFI inviting comments and guidance to be considered during the development of a prize competition to advance delivery technologies that fully realize the promise of somatic genome editing to reduce disease burden.